In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

  • Lola helped us tremendously in navigating the process with Cancer Commons, taking the time to explain findings. The Cancer Commons report is very helpful in exploring treatment alternatives that my oncologists may not have considered yet.

    Francois
    Pancreatic cancer patient

  • Whenever we needed them they were there. Whenever we needed new information or help finding a new treatment they were there immediately. They were such a pleasure to deal with that they were like a family member helping you out, and believe me I/we needed them. 

    Dr. Mel Burchman
    Spouse of a pancreatic cancer patient
  • Glioblastoma is devastating, and Cancer Commons made excellent recommendations to present to our medical team. They know what they are doing and have the experts that can sift through the voluminous mountain of research.

    Glory Cochrane
    Wife of glioblastoma patient

  • Emma not only helped me when I first reached out, but she continues to catch up with me and keep up with me. I consider her my friend.

    Grace
    Anal cancer patient

  • Absolutely wonderful!! Matt is a wealth of knowledge and so prompt at getting back to emails and reporting findings or results. It really is incredible to have this resource free of charge as a second opinion, and gives me comfort knowing what we are doing is the best we can do for now, leaving no stone unturned. We appreciate Cancer Commons so very much!!

    Jessica
    Daughter of a grade IV glioblastoma patient

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.